Immortality and Deep Space Exploration: Why Human Longevity May Determine Whether We Reach the Stars

As an Amazon Associate we earn from qualifying purchases.

Key Takeaways

• Human lifespan remains the most stubborn barrier to crewed interstellar travel
• Longevity biotech companies are pouring billions into slowing and reversing human aging
• Suspended animation research may be the most near-term viable solution for long voyages

The Arithmetic Nobody Wants to Do

Alpha Centauri, the closest star system to our own, is 4.37 light-years away. NASA‘s Voyager 1, the fastest human-made object ever to leave the solar system, travels at roughly 17 kilometers per second. At that speed, it would take approximately 73,000 years to reach Alpha Centauri. Not decades. Not centuries. Seventy-three thousand years.

The most ambitious proposed propulsion project for interstellar travel, Breakthrough Starshot, envisions laser-propelled probes traveling at 20 percent of the speed of light. Even at that velocity, a crewed mission to Alpha Centauri would take about 22 years each way, consuming nearly half a human lifetime under ideal conditions. Those conditions don’t exist yet.

There’s a math problem embedded in every serious conversation about deep space exploration, and it has nothing to do with rocket engines or fuel efficiency. It has to do with biology. Human beings live, on average, around 73 years globally, and even in the longest-lived populations, rarely past 100. Against the distances involved in interstellar travel, that’s a rounding error. The question of whether humanity can ever become a multistellar species may rest less on engineering and more on whether people can live long enough to make the journey worthwhile.

What Biology Actually Does to the Human Body Over Time

Aging isn’t a disease in the traditional sense, but researchers at the SENS Research Foundation have argued convincingly that it behaves like one. The body accumulates damage at the cellular and molecular level over time, and that damage compounds. Telomeres, the protective caps at the ends of chromosomes, shorten with each cell division. Mitochondria, which generate most of a cell’s energy supply, accumulate mutations and become less efficient. Cross-links form between proteins, stiffening tissues and degrading organ function. Senescent cells, which stop dividing but refuse to die, accumulate and release inflammatory signals that harm surrounding tissue.

None of this happens quickly. A 30-year-old barely notices any of it. By 70, the cumulative weight of these changes becomes visible in ways ranging from reduced cardiovascular capacity to slower wound healing to increased cancer risk.

For a crewed mission to any destination beyond Mars, this biological timeline creates an almost impossible constraint. A mission to Jupiter’s moon Europa, which NASA’s Europa Clipper is visiting in a flyby context but which a crewed mission would require years to reach, would demand astronauts who could maintain peak physical and cognitive function over timescales that current biology simply doesn’t support reliably. Push the destination to the outer solar system or beyond, and the problem becomes insurmountable without some form of intervention.

The Hayflick limit, named after biologist Leonard Hayflick who identified it in 1961, describes the finite number of times a normal human cell can divide before it stops, sitting at around 40 to 60 divisions. It was once thought to represent an inescapable ceiling on lifespan itself, though researchers have since found that the relationship between cellular senescence and organismal aging is considerably more complicated. Still, the Hayflick limit illustrates a core tension: human cells were not designed by evolution for indefinite operation.

The Longevity Labs and What They’re Actually Working On

In 2013, Google created Calico, a life sciences company with a single stated mission of understanding the biology of aging and developing interventions to extend healthy human life. The company has operated largely in secrecy since then, publishing relatively few results while maintaining a research partnership with AbbVie. Calico’s approach focuses on fundamental biology, with particular attention to the pathways that regulate lifespan in model organisms like yeast, worms, and mice.

Then in 2021, a group of notable investors including Jeff Bezos and Yuri Milner funded Altos Labs, a startup that recruited some of the world’s top cellular reprogramming scientists. Altos operates on the premise that cells can be partially reset to a younger state using a set of proteins first identified by Shinya Yamanaka, who won the Nobel Prize for discovering induced pluripotent stem cells in 2006. The Yamanaka factors can reprogram adult cells back into a stem-cell-like state, and Altos is attempting to use partial reprogramming, applying these factors briefly and incompletely, to rejuvenate cells without erasing their identity entirely.

This work isn’t science fiction. Researchers at the Salk Institute demonstrated in 2016 that partial reprogramming could extend the lifespan of mice with a premature aging disorder. David Sinclair at Harvard Medical School has published work showing that epigenetic reprogramming can restore vision in aging mice by reversing age-related changes in retinal cells. His book Lifespan lays out a theory that aging itself is an epigenetic phenomenon, essentially information corruption over time, that could in principle be corrected.

The SENS Research Foundation, co-founded by biomedical gerontologist Aubrey de Grey, takes a more engineering-driven view. De Grey’s framework, laid out in his book Ending Aging, categorizes aging damage into seven distinct types and proposes specific repair strategies for each. The approach has been controversial within academic biology, where many researchers resist framing aging as something to be fixed rather than managed. But several of the individual strategies SENS has proposed, including senolytics (drugs that selectively clear senescent cells), have since entered clinical trials and gained mainstream scientific acceptance.

Senolytics deserve specific attention here. The first clinical trial of a senolytic drug in humans began in 2018 at the Mayo Clinic, using a combination of dasatinib and quercetin in patients with a specific lung disease. Results suggested that clearing senescent cells could improve physical function. Unity Biotechnology, a San Francisco company, has been running trials of senolytic treatments for age-related eye conditions. This is no longer speculative territory.

Cryonics: The Oldest Solution to the Longest Problem

Long before anyone was talking about epigenetic reprogramming, science fiction writers imagined a simpler answer to the time problem in space: freeze the crew and wake them up when they arrive. The film Passengers put this concept on screen in 2016, though it bent the premise for dramatic purposes. 2001: A Space Odyssey depicted hibernating astronauts as early as 1968. The idea feels familiar, maybe even dated. But the underlying science has moved in ways that deserve serious attention.

Cryonics as practiced today, primarily by organizations like the Alcor Life Extension Foundation in Scottsdale, Arizona, involves cooling recently deceased individuals to cryogenic temperatures in the hope that future technology will allow revival. This is not the same as suspended animation for space travel. Alcor works with people who have legally died, using vitrification (a process that replaces body water with a cryoprotectant solution to prevent ice crystal damage) before cooling them to minus 196 degrees Celsius in liquid nitrogen. As of early 2024, Alcor had preserved roughly 200 patients. It’s a genuinely strange practice, and the honest scientific consensus is that successful revival remains speculative.

But suspended animation for living patients is a different and considerably more advanced field. Surgeons at the University of Maryland Medical Center began a clinical trial in 2019 involving emergency preservation and resuscitation, a procedure in which patients experiencing traumatic cardiac arrest are rapidly cooled by replacing their blood with cold saline. This stops cellular activity for up to an hour, giving surgeons time to repair injuries that would otherwise be fatal. The technique buys time without killing the patient. It’s not indefinite hibernation, but it demonstrates that human metabolism can be suspended temporarily under controlled conditions.

SpaceWorks Enterprises, an Atlanta-based aerospace company, has received funding from NASA to study torpor-inducing systems for long-duration spaceflight. Their concept involves cooling crew members to around 32 degrees Celsius and keeping them in a state of reduced metabolic activity for weeks at a time, similar to what hospitals use for therapeutic hypothermia after cardiac events. The company published feasibility assessments suggesting that such a system could reduce the required consumables (food, water, oxygen) by significant margins on a Mars mission, which would reduce launch mass and overall cost. It remains a concept study, not a flight-ready system, but the underlying physiology is not imaginary.

The film Interstellar, released in 2014 and produced in close collaboration with physicist Kip Thorne, sidesteps the hibernation problem by using relativistic time dilation near a black hole. That solution is physically plausible but practically irrelevant for the near future. More grounded proposals involve some combination of metabolic suppression, radiation shielding, and mission timelines calibrated to human lifespans. None of them are fully satisfying on their own.

The Mind Uploading Question

Here’s where the certainty starts to erode. Discussions about immortality in deep space consistently circle back to the idea of uploading human consciousness to a digital substrate. If the mind can run on something other than biological neurons, then a spacecraft doesn’t need to keep a human body alive for 22 years. It needs to preserve a digital file.

The philosophical and technical difficulties here are genuinely hard to separate. On the technical side, Ray Kurzweil at Google has predicted for years that brain emulation at sufficient resolution will be possible by 2029, basing that prediction on extrapolations of computing power and neuroscience progress. The Human Connectome Project, a large-scale research initiative that mapped the neural connections of small brain regions in unprecedented detail, has demonstrated that the structural complexity of the brain is orders of magnitude beyond anything current technology can fully resolve. Mapping the complete connectome of a human brain, all 86 billion neurons and roughly 100 trillion synaptic connections, remains far beyond current capability. Progress is real but slow.

On the philosophical side, the question is whether a digital copy of a mind is the same person or a different person who happens to share memories and personality. This is not a question science can currently answer, and it’s not clear that it ever can. If a person’s consciousness is scanned and uploaded at the moment of departure, the upload arrives 22 years later at Alpha Centauri, but the original biological person dies during the journey (or perhaps lives out their life on Earth), has anyone actually traveled? The problem doesn’t go away if the biology survives the journey either. A person who arrives at Alpha Centauri after 22 years in torpor has aged physiologically by some amount, changed psychologically by the experience, and is arguably a different person from the one who departed. The continuity of identity question haunts every proposed solution to the time problem in deep space, not just mind uploading specifically.

Generation Ships and the Consent Problem

A different approach to the timescale problem involves sending a large enough population of people that they can reproduce across multiple generations, with descendants arriving at the destination that ancestors will never see. This is the generation ship concept, and it has a philosophical problem that doesn’t get enough attention.

The people who are born on the ship during the journey didn’t consent to being born into a life with a fixed destination and no practical alternative. The descendants who arrive at the target system didn’t choose that journey. The ethical questions about who gets to make that decision for future generations are real and remain unresolved. Philosopher Toby Ord at Oxford University has written about existential risks in ways that touch on these questions, though the generation ship case specifically sits in legal and ethical territory that hasn’t been formally worked through.

There are also genetic considerations. Maintaining sufficient genetic diversity in a multigenerational population confined to a spacecraft would require careful planning. Population geneticists have estimated that a minimum viable population for a multigenerational voyage might require at least several hundred individuals, possibly over a thousand, to avoid the accumulation of genetic disorders through inbreeding over the necessary timescales. That’s a very large spacecraft, with enormous resource requirements, and a logistical challenge that dwarfs anything humanity has attempted in space.

Longevity research could sidestep the generation ship problem entirely. If a crew member launched at 30 years old could remain in peak physical condition for 200 years through biological intervention, a 50-year mission to a nearby star system becomes plausible without hibernation, generation ships, or philosophical debates about digital consciousness. That’s why the two fields, longevity research and deep space exploration, are more connected than they might appear.

What the Propulsion Side Looks Like

The propulsion problem and the longevity problem are tightly coupled because any solution to one changes the requirements for the other. Current chemical rockets can get humans to Mars in roughly seven months. Nuclear thermal propulsion, which NASA and DARPA are actively developing through their DRACO (Demonstration Rocket for Agile Cislunar Operations) program, could cut transit times to Mars to as little as three or four months. That’s meaningful for Mars missions but doesn’t change the interstellar math.

Nuclear pulse propulsion, originally studied in the late 1950s under Project Orion, remains the most physically plausible concept for achieving significant fractions of the speed of light without exotic physics. The idea involves detonating nuclear bombs behind the spacecraft and using the shock waves for thrust. Freeman Dyson, one of the original physicists on the project before it was cancelled by the Partial Nuclear Test Ban Treaty of 1963, believed it could achieve speeds of around 3 to 10 percent of the speed of light. At 10 percent of light speed, a trip to Alpha Centauri would take about 44 years. Long, but within a single human lifetime, if that human is in exceptional health throughout.

More exotic concepts, like the Alcubierre drive (which involves compressing space-time ahead of a spacecraft and expanding it behind), are mathematically interesting but require forms of matter with negative energy density that may not exist. The Breakthrough Starshot project, backed by physicist Stephen Hawking before his death in 2018 and funded by Yuri Milner and Mark Zuckerberg among others, proposes launching gram-scale probes (not crewed vehicles) at 20 percent of light speed using ground-based laser arrays. Crewed missions at that scale remain far beyond current engineering.

The practical upshot: even with the most optimistic propulsion scenarios that don’t require physics we haven’t discovered yet, crewed interstellar travel implies mission durations measured in decades. Biology has to solve for decades, not centuries, to make this work. That’s a different and considerably more tractable target than immortality in the literal sense.

Radiation: The Problem That Gets Underweighted

Space radiation is different from the radiation exposure people experience on Earth in both type and intensity. Galactic cosmic rays, high-energy particles from outside the solar system, penetrate conventional spacecraft shielding and pass through human tissue, causing DNA strand breaks and potentially increasing cancer risk substantially over long missions.

NASA astronauts on the International Space Station are exposed to roughly 150 to 200 millisieverts of radiation per year, which is considerably more than the 6 millisieverts the average American receives annually but still manageable for shorter missions. On a multi-year Mars mission, radiation exposure would be substantially higher. On an interstellar trajectory outside the protective heliosphere entirely, the dose rates would be higher still, and there is no known shielding technology today that can adequately protect biological tissue over decade-long exposures at those levels.

This matters for longevity in space because even if biological aging can be slowed or halted at the cellular level, radiation damage represents a continuous insult to DNA that requires ongoing repair. Some organisms handle this remarkably well. Deinococcus radiodurans, a bacterium sometimes called “Conan the Bacterium,” can survive radiation doses thousands of times lethal to humans by rapidly repairing its own DNA. Understanding those mechanisms has been an active area of research, with some scientists speculating that components of those systems could eventually be incorporated into human gene therapies. That’s a long way from clinical reality, but the existence of organisms with extreme radiation resistance demonstrates that biology can, in principle, handle radiation environments that would be fatal to unmodified humans.

The Ethics of Who Gets to Live Forever

This is where the conversation about immortality and space exploration intersects with politics in ways that are uncomfortable to think through. Longevity interventions, if they work, will almost certainly be expensive when first developed. The history of medical technology is essentially the history of expensive treatments becoming cheaper over time, but the gap between “available” and “universally accessible” can span decades.

If significantly extended lifespans become available only to the wealthy, the social implications are considerable. A world in which the rich live centuries while the poor live normal lifespans would be, by any coherent definition, a more unequal world than the one that exists today. Political philosopher John Rawls argued that social arrangements should be evaluated from behind a “veil of ignorance,” without knowing one’s place in the resulting society. A longevity technology available only to billionaires would fail that test dramatically.

For deep space specifically, this means that the first people to go to the stars (if they’re going on extended missions made possible by longevity interventions) will likely be either extraordinarily wealthy or selected through programs run by governments or agencies with their own selection criteria. Neither scenario is particularly democratic. Space agencies like NASA, ESA, ISRO, and CNSA are government bodies with at least nominal public accountability. SpaceX, Blue Origin, and Virgin Galactic are private companies. The decisions about who gets longevity treatments and who goes to space will be made within existing frameworks of wealth, power, and institutional priority, and that shapes everything downstream.

A Comparison of Proposed Approaches

The table below compares the primary approaches to addressing human lifespan limitations in the context of deep space exploration.

The AI Factor

Artificial intelligence changes this discussion in ways that haven’t been fully integrated into mainstream thinking about long-duration spaceflight. An AI system doesn’t age, doesn’t require food or oxygen, doesn’t accumulate radiation damage in the same way biological tissue does, and can operate continuously for decades without the psychological deterioration that isolation inflicts on human crews. If AI continues to develop at the pace it has shown since 2020, the question of whether humans need to be physically present during the transit portion of interstellar missions becomes genuinely open.

A plausible model involves a small crew in deep hibernation or induced torpor, monitored and managed by an advanced AI system, with humans brought to consciousness only when decision-making or physical intervention is required. The AI handles navigation, system maintenance, anomaly detection, and routine science during the transit. Humans provide judgment, adaptability, and the institutional legitimacy that comes with actually being present at the destination.

OpenAI, DeepMind, and Anthropic are all working on AI systems with increasingly sophisticated reasoning capabilities. Projecting what AI will look like in 30 or 50 years is genuinely uncertain, but there’s a reasonable argument that autonomous AI capable of managing a spacecraft for decades is closer to realization than biological immortality. That changes the minimum threshold that longevity science needs to meet. If AI can handle a 20-year transit, biology only needs to keep humans healthy enough to thrive at the destination, not throughout the entire journey.

What Extremophile Biology Tells Us

Some of the most instructive data on lifespan extension doesn’t come from human biology at all. The Greenland shark has been confirmed to live at least 400 years, making it the longest-lived vertebrate known. The ocean quahog clam, Arctica islandica, has been documented living over 500 years. The naked mole-rat, a small rodent native to East Africa, lives up to 30 years in captivity (roughly ten times longer than similarly sized mice) and shows almost no age-related increase in cancer risk.

The naked mole-rat is particularly interesting from a research perspective. Rochelle Buffenstein at the Calico Research Institute (formerly at the University of Texas Health Science Center) has studied the animal for decades and found that its cancer resistance appears to involve both enhanced DNA repair mechanisms and a sugar molecule called high molecular weight hyaluronic acid that seems to prevent uncontrolled cell growth. These mechanisms are being actively studied for potential applicability to human biology.

Nature has already run many independent experiments in extreme longevity, using mechanisms that evolved for entirely different reasons. Evolution didn’t design Greenland sharks to be useful research subjects, but their existence proves that vertebrate biology can sustain function for centuries given the right physiological architecture. Understanding why they live so long, and which of those mechanisms can be translated to human cells, is a legitimate and active area of research.

The Psychological Dimension of Long Missions

There’s a dimension to long-duration spaceflight that purely biological approaches to immortality don’t address. Human psychology wasn’t built for isolation, confinement, and the existential weight of traveling through empty space for years or decades. The Mars-500 study, conducted by the European Space Agency and the Russian Institute for Biomedical Problems between 2010 and 2011, isolated six volunteers in a simulated spacecraft for 520 days. The results were instructive: some crew members showed signs of depression and sedentary behavior as the mission progressed, and sleep patterns deteriorated across the group.

A body that doesn’t age biologically can still suffer psychologically. The relationship between mental health and physical health is well-documented enough that psychological deterioration would likely produce physical consequences over multi-decade missions even in biologically young crews. NASA has been studying crew psychology for decades through its Human Research Program, focusing on isolation, behavioral health, and cognitive performance over time. What the agency hasn’t done yet is study crews over timescales relevant to interstellar missions, because no humans have been in space continuously for more than about a year and a half. Russian cosmonaut Valeri Polyakov set the record with 437 consecutive days on the Mir space station between 1994 and 1995, a benchmark that remains unbroken decades later.

The Case for Suspended Animation Over Biological Immortality

There’s a clear argument to be made here, and it’s worth making directly: for the near to medium term, suspended animation is almost certainly more achievable than biological immortality, and more appropriate for the specific problem of deep space travel. The two ideas often get conflated in popular discussions, but they’re solving different problems.

Biological immortality, or even a dramatic extension of healthy human lifespan, would be one of the most consequential developments in human history, and its implications for society, economics, and culture would take generations to work through. The research is genuinely exciting and the pace of progress in areas like senolytics and epigenetic reprogramming is faster than most people outside the field realize. But timescales for clinical application in healthy individuals are almost certainly measured in decades, not years.

Suspended animation for space travel is a more targeted problem. It doesn’t require solving aging broadly; it requires inducing reversible metabolic suppression in healthy adults for defined periods. The underlying science is different, the clinical pathway is shorter, and the applications are more specific. SpaceWorks’ torpor concept, which builds on therapeutic hypothermia already used in hospitals, represents a more direct line from current capability to mission-ready technology than any biological immortality approach currently under development.

The films and books that shaped public understanding of this problem often collapse these distinctions in ways that muddy thinking. The Martian by Andy Weir, which became a major film in 2015, dealt brilliantly with survival on Mars but sidestepped the multi-generational timescale problem entirely by keeping the mission duration within a single human life. Kim Stanley Robinson’s Aurora, published in 2015, grapples more honestly with the biological and social challenges of a multigenerational voyage and reaches a conclusion that most space advocates find uncomfortable.

The Convergence of Medicine and Mission Planning

What’s emerging, slowly and without much fanfare, is a synthesis between space medicine and longevity medicine that could reshape both fields. NASA has been studying the effects of long-duration spaceflight on human biology through programs like the Twin Study, in which astronaut Scott Kelly spent nearly a year on the International Space Station while his identical twin brother Mark Kelly remained on Earth. The results showed measurable changes in Scott Kelly’s telomere length, gene expression, gut microbiome, and cognitive performance, some of which persisted after his return to Earth.

That data matters because it directly links the challenges of long-duration spaceflight to the mechanisms that longevity researchers are working to address. Telomere dynamics, epigenetic changes, microbiome disruption, and cognitive aging are all active areas in geroscience. A NASA investment in understanding how spaceflight affects these systems isn’t separate from longevity research; it is longevity research, conducted in the most extreme environment available.

There’s a productive feedback loop here. Space forces the pace of biology research because the stakes are obvious and the problems are hard. Biology, if it succeeds in extending healthy human lifespan, changes what’s possible in space. The two fields have more shared interest than either tends to acknowledge publicly, and the collaborations that could accelerate both remain, so far, underdeveloped.

Summary

All the technical arguments about propulsion, hibernation, radiation shielding, and biological aging eventually come back to a simpler question: what kind of beings will be doing this travel, and what will they be capable of by the time humanity is actually ready to attempt it? The version of deep space exploration that involves unmodified humans on decade-long voyages in conventional spacecraft runs into problems that can’t be solved with better engineering alone.

What’s often missing from discussions about longevity and space travel is how deeply the political economy of mortality shapes human institutions. Governments that operate on four-year election cycles don’t naturally invest in 50-year missions. Corporations that answer to quarterly earnings don’t naturally fund research whose payoff is 30 years away. If extended lifespan becomes real, if the people making decisions today expect to live long enough to see the consequences of those decisions, the time horizons of institutions might shift in ways that make sustained investment in deep space exploration structurally easier to justify. That argument doesn’t appear in most technical papers on longevity or propulsion, but it may be the most consequential connection between the two fields, and the one most worth watching.

Appendix: Top 10 Questions Answered in This Article

How far is the nearest star system from Earth, and how long would it take to get there?

Alpha Centauri is approximately 4.37 light-years from Earth. At the speed of Voyager 1, about 17 kilometers per second, reaching it would take around 73,000 years. Even the most ambitious proposed concept, Breakthrough Starshot, envisions probes traveling at 20 percent of light speed and taking roughly 22 years to arrive, though crewed missions at that scale remain far beyond current engineering.

What biological mechanisms cause human aging?

Aging results from accumulated damage at the cellular and molecular level, including telomere shortening, mitochondrial mutations, protein cross-linking, and the accumulation of senescent cells that release inflammatory signals. These changes compound over decades and eventually lead to reduced organ function, increased cancer risk, and systemic decline. The process is well-characterized at the biological level, and multiple research programs are now targeting specific components of it with therapeutic interventions.

What is the SENS Research Foundation and what does it do?

The SENS Research Foundation, co-founded by biomedical gerontologist Aubrey de Grey, approaches aging as a form of accumulated biological damage that can be addressed through targeted medical repair. It categorizes aging into seven distinct damage types and funds research into specific repair strategies, including senolytics (drugs that clear dysfunctional senescent cells) and mitochondrial repair. Several of its proposed strategies have since entered mainstream clinical development.

What is suspended animation and how close is it to being used in space missions?

Suspended animation involves inducing a reversible state of reduced metabolic activity in a living person to extend survival time without the normal progression of physiological aging. Hospitals already use a limited form through therapeutic hypothermia after cardiac events. Companies like SpaceWorks Enterprises have received NASA funding to develop torpor-induction systems for long-duration spaceflight, though these remain at the concept study stage and are not yet flight-ready.

What is cryonics and does it currently work?

Cryonics involves preserving legally deceased individuals at extremely low temperatures using vitrification, which replaces body water with cryoprotectant solutions to prevent ice crystal damage, in the hope that future technology will allow revival. Organizations like the Alcor Life Extension Foundation in Arizona currently store around 200 patients this way. Revival from cryonic preservation has not been demonstrated in humans and remains scientifically speculative.

What did the NASA Twin Study reveal about spaceflight and aging?

The NASA Twin Study compared astronaut Scott Kelly, who spent nearly a year on the International Space Station, with his identical twin brother Mark Kelly on Earth. It found measurable changes in Scott’s telomere length, gene expression, gut microbiome composition, and cognitive performance, some of which persisted months after he returned to Earth. The study directly linked long-duration spaceflight to mechanisms that longevity researchers are actively studying, confirming that space accelerates some aspects of biological aging.

What is epigenetic reprogramming and could it extend human lifespan?

Epigenetic reprogramming uses proteins originally identified by Shinya Yamanaka to partially reset cells to a more youthful functional state by reversing changes in how genes are expressed, without altering the underlying DNA sequence. Companies like Altos Labs are investigating whether partial reprogramming can rejuvenate aging cells and tissues in living organisms. Research at the Salk Institute demonstrated in 2016 that partial reprogramming extended lifespan in mice with a premature aging disorder, supporting the concept as a serious avenue for development.

What is a generation ship and why does it pose ethical problems?

A generation ship is a spacecraft large enough to sustain multiple generations of people across an interstellar voyage, with descendants arriving at a destination their ancestors will never reach. The central ethical problem is that people born during the voyage never consented to their circumstances, destination, or the fundamental conditions of their lives. Maintaining adequate genetic diversity across generations also requires minimum population sizes that population geneticists estimate could range from several hundred to over a thousand individuals.

Why is radiation particularly dangerous for long-duration spaceflight?

Space radiation, especially galactic cosmic rays originating outside the solar system, penetrates conventional shielding and causes DNA strand breaks in human tissue that accumulate over time. Outside the sun’s heliosphere, dose rates are substantially higher than in low Earth orbit, where astronauts already receive around 150 to 200 millisieverts annually. Even crews with biologically extended lifespans would face continuous radiation-induced DNA damage that no current longevity intervention directly addresses, making radiation shielding an independent and largely unsolved engineering challenge.

How could artificial intelligence reduce the longevity requirements for interstellar crews?

Advanced AI systems don’t age, don’t require food or oxygen, and can manage spacecraft operations continuously for decades without psychological deterioration. If AI can autonomously handle navigation, maintenance, and anomaly detection during a transit phase, a small human crew could remain in hibernation or torpor and only be awakened at the destination. This changes the biological requirement from sustaining peak human health across the entire journey to simply preserving crew members well enough to function effectively on arrival, a considerably lower bar than true biological immortality.